Exor (ENXTAM:EXO) has quietly slipped over the past year, with shares down around 23% even as its underlying holdings like Ferrari and Stellantis keep executing. That gap is exactly what value focused ...
Exor acquired a 15% equity stake in Philips, worth approximately €2.6 billion, confirming its repositioning in the healthcare sector. €2 billion of additional cash available for new investments, with ...
Exor faces challenges with Stellantis and CNH, but Ferrari's strong performance bolsters its financial stability. Exor's strategic shift towards luxury brands and healthcare indicates a potential move ...
Exor N.V. (EXO) reported a decline in net asset value (NAV) per share for the second half of 2025, reflecting challenges in its major holdings such as Ferrari, Stellantis, and CNH. Despite a robust ...
Exor, the holding company of Italy's Agnelli family, will have about 9 billion euros ($10.2 billion) available for investments next year once it completes the sale of reinsurer PartnerRe, Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results